Fas activation in alveolar epithelial cells induces KC (CXCL1) release by a MyD88-dependent mechanism

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 3, 2011, Pages 650-658

  Farnand, Alex W ^a   Eastman, Alison J ^a   Herrero, Raquel ^a   Hanson, Josiah F ^a   Mongovin, Steve ^a   Altemeier, William A ^a   Matute Bello, Gustavo ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Fas; Fas ligand; IL 8; KC; MyD88

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADAPTOR PROTEIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CXCL1 CHEMOKINE; FAS LIGAND; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; ANTIGENS, CD95; CHEMOKINE CXCL1; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FAS LIGAND PROTEIN; INTERLEUKIN-8; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PULMONARY ALVEOLI; RNA, SMALL INTERFERING; TRANSFECTION;

MURINAE; MUS;

EID: 80052542285     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0153OC     Document Type: Article

References (38)

1. Erickson S.E., Martin G.S., Davis J.L., Matthay M.A., Eisner MD, and NIH NHLBI ARDS Network. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37:1574-1579.
2. Phua J., Badia J.R., Adhikari N.K., Friedrich J.O., Fowler R.A., Singh J.M., Scales D.C., Stather D.R., Li A., Jones A., et al. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 2009;179:220-227.
3. Cooke C.R., Kahn J.M., Watkins T.R., Hudson L.D., Rubenfeld G.D. Costeffectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 2009;136:79-88.
4. Matthay M.A., Zimmerman G.A., Esmon C., Bhattacharya J., Coller B., Doerschuk C.M., Floros J., Gimbrone M.A., Hoffman E., Hubmayr R.D., et al. Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003;167:1027-1035. (Pubitemid 36408170)
5. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-243. (Pubitemid 121001362)
6. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178. (Pubitemid 24006113)
7. Rensing-Ehl A., Hess S., Ziegler-Heitbrock H.W., Riethmüller G., Engelmann H. Fas/Apo-1 activates nuclear factor kB and induces interleukin-6 production. J Inflamm 1995;45:161-174.
8. Strasser A., Jost P.J., Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009;30:180-192.
9. Matute-Bello G., Liles W.C., Steinberg K.P., Kiener P.A., Mongovin S., Chi E.Y., Jonas M., Martin T.R. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999;163:2217-2225. (Pubitemid 29382230)
10. Lee K.S., Choi Y.H., Kim Y.S., Baik S.H., Oh Y.J., Sheen S.S., Park J.H., Hwang S.C., Park K.J. Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir Med 2008;102:464-469 (Pubitemid 351179973)
11. Albertine K.H., SoulierM.F.,Wang Z., Ishizaka A., Hashimoto S., Zimmerman G.A., Matthay M.A., Ware L.B. Fas and Fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 2002;161:1783-1796. (Pubitemid 35265536)
12. Matute-Bello G., Winn R.K., Jonas M., Chi E.Y., Martin T.R., Liles W.C. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation. Am J Pathol 2001;158:153-161. (Pubitemid 32096480)
13. Park D.R., Thomsen A.R., Frevert C.W., Pham U., Skerrett S.J., Kiener P.A., Liles W.C. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 2003;170:6209-6216. (Pubitemid 36682605)
14. Perl M., Chung C.S., Perl U., Lomas-Neira J., De Paepe M., Cioffi W.G., Ayala A. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med 2007;176:591-601. (Pubitemid 47403277)
15. Matute-Bello G., Lee J.S., Liles W.C., Frevert C.W., Mongovin S., Wong V., Ballman K., Sutlief S., Martin T.R. Fas-mediated acute lung injury requires Fas expression on nonmyeloid cells of the lung. J Immunol 2005;175:4069-4075. (Pubitemid 41292070)
16. Miwa K., Asano M., Horai R., Iwakura Y., Nagata S., Suda T. Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998;4:1287-1292. (Pubitemid 28512110)
17. Matute-Bello G., Liles W.C., Frevert C.W., Nakamura M., Ballman K., Vathanaprida C., Kiener P.A., Martin T.R. Recombinant human Fas-ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2001;281:L328-L335.
18. Matute-Bello G., Winn R.K., Martin T.R., Liles W.C. Sustained lipopolysaccharide-induced lung inflammation in mice is attenuated by functional deficiency of the Fas/Fas ligand system. Clin Diagn Lab Immunol 2004;11:358-361. (Pubitemid 38380818)
19. Bem R.A., Farnand A.W., Wong V., Koski A., Rosenfeld M.E., Van Rooijen N., Frevert C.W., Martin T.R., Matute-Bello G. Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2008;295:L314-L325.
20. Perl M., Chung C.S., Lomas-Neira J., Rachel T.M., Biffl W.L., Cioffi W.G., Ayala A. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 2005;167:1545-1559. (Pubitemid 41713309)
21. Matute-Bello G., Wurfel M.M., Lee J.S., Park D.R., Frevert C.W., Madtes D.K., Shapiro S.D., Martin T.R. Essential Role of MMP-12 in Fasinduced lung fibrosis. Am J Respir Cell Mol Biol 2007;37:210-221. (Pubitemid 47255004)
22. Matute-Bello G., Frevert C.W., Kajikawa O., Skerrett S.J., Goodman R.B., Park D.R., Martin T.R. Septic shock and acute lung injury in rabbits with peritonitis: Failure of the neutrophil response to localized infection. Am J Respir Crit Care Med 2001;163:234-243. (Pubitemid 32095275)
23. Matute-Bello G., Liles W.C., Frevert C.W., Dhanireddy S., Ballman K., Wong V., Green R.R., Song H.Y., Witcher D.R., Jakubowski J.A., et al. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen. J Infect Dis 2005;191:596-606. (Pubitemid 40216676)
24. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997;7:837-847. (Pubitemid 28064897)
25. Bannerman D.D., Tupper J.C., Kelly J.D., Winn R.K., Harlan J.M. The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta. J Clin Invest 2002;109:419-425. (Pubitemid 34141816)
26. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483.
27. De Paepe M.E., Gundavarapu S., Tantravahi U., Pepperell J.R., Haley S.A., Luks F.I., Mao Q. Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development. Am J Pathol 2008;173:42-56. (Pubitemid 351947954)
28. Hamann K.J., Dorscheid D.R., Ko F.D., Conforti A.E., Sperling A.I., Rabe K.F., White S.R. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium. Am J Respir Cell Mol Biol 1998;19:537-542. (Pubitemid 128354234)
29. Kiener P.A., Davis P.M., Rankin B.M., Klebanoff S.J., Ledbetter V.A., Starling G.C., Liles W.C. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation. J Immunol 1997;159:1594-1598. (Pubitemid 127484141)
30. Wadsworth S.J., Atsuta R., McIntyre J.O., Hackett T.L., Singhera G.K., Dorscheid D.R. IL-13 and Th2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. J Allergy Clin Immunol 2010;126:366-374.
31. Schaub F.J., Han D.K., Liles W.C., Adams L.D., Coats S.A., Ramachandran R.K., Seifert R.A., Schwartz S.M., Bowen-Pope D.F. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 2000;6:790-796. (Pubitemid 30469428)
32. Siegmund D., Mauri D., Peters N., Juo P., Thome M., Reichwein M., Blenis J., Scheurich P., Tschopp J., Wajant H. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. J Biol Chem 2001;276:32585-32590.
33. Kreuz S., Siegmund D., Rumpf J.J., Samel D., Leverkus M., Janssen O., Häcker G., Dittrich-Breiholz O., Kracht M., Scheurich P., et al. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 2004;166:369-380. (Pubitemid 39031240)
34. Yang X., Khosravi-Far R., Chang H.Y., Baltimore D. DAXX, a novel Fasbinding protein that activates JNK and apoptosis. Cell 1997;89:1067-1076. (Pubitemid 127678740)
35. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81:495-504.
36. Ting A.T., Pimentel-Muiños F.X., Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF- KappaB but not Fas/APO-1 - Initiated apoptosis. EMBO J 1996;15:6189-6196. (Pubitemid 26397891)
37. Altemeier W.A., Zhu X., Berrington W.R., Harlan J.M., Liles W.C. Fas (CD95) induces macrophage proinflammatory chemokine production via aMyD88-dependent, caspase-independent pathway. J Leukoc Biol 2007;82:721-728. (Pubitemid 47367164)
38. Patel D.N., Bailey S.R., Gresham J.K., Schuchman D.B., Shelhamer J.H., Goldstein B.J., Foxwell B.M., Stemerman M.B., Maranchie J.K., Valente A.J., et al. TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells. Biochem Biophys Res Commun 2006;347:1113-1120. (Pubitemid 44118229)